Search
Etelcalcetide
go.drugbank.com/drugs/DB12865ApprovedInvestigationalEtelcalcetide was approved (trade name Parsabiv) for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis in February, 2017. … Etelcalcetide is a calcimimetic drug for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis.
Products: Parsabiv 5mg solution for injection, PARSABIV SOLUTION FOR INJECTION 5 mg/mLCarbopol 974P
go.drugbank.com/drugs/DB05384ApprovedWithdrawnThe compound, known as BufferGel, was in advanced clinical trials for its ability to prevent pregnancy, but was discontinued. … Carbopol 974P is a highly carboxylated polymer composed of lightly cross-linked polyacrylic acid with a broad-spectrum mechanism based on acidification of pathogens.
Categories: Compounds used in a research, industrial, or household settingProducts: LIQUIGEL UD 2.5MG/G EINZELZinc gluconate
go.drugbank.com/drugs/DB11248ApprovedInvestigationalVet approvedup to 12 weeks [L422]. … Zinc gluconate is a zinc salt of gluconic acid comprised of two gluconic acid molecules for each zinc cation (2+). Zinc gluconate is a generally recognized as safe (GRAS) substance by FDA [L2081].
Mixtures: Super Daily No 2, Multi-force for Women TabCategories: Agents for Treatment of Hemorrhoids and Anal Fissures for Topical UseL-arginine
go.drugbank.com/drugs/DB17289ApprovedInvestigationalNutraceuticalMixtures: AMINOVEN SOLUTION FOR INFUSION 15%, Vamin NProducts: LYSAKARE SOLUTION FOR INFUSION 25G / 25GBrimonidine
go.drugbank.com/drugs/DB00484ApprovedInvestigational[A178945] Thus brimonidine is an effective and safe alternative to beta-blockers, in patients with, or at high risk for, cardiopulmonary disease. … [A178948] The topical form of brimonidine was approved by the FDA in August 2013 for the symptomatic treatment of persistent facial erythema of rosacea in adults.
Mixtures: Brim-Dor PF, Tim-Brim-Dor PFCategories: Sympathomimetics in Glaucoma TherapyPlerixafor
go.drugbank.com/drugs/DB06809ApprovedInvestigational[A7117] Compared to placebo with G-CSF, the plerixafor and G-CSF mobilization regimen has a higher probability of achieving the optimal CD34+ cell target for tandem transplantation in fewer apheresis procedures … [A7115] Plerixafor has orphan drug status in the United States and European Union and was approved by the US Food and Drug Administration on December 15, 2008.[A7117,L45678]
Products: Mozobil 20 mg/ml solution for injection, Mozobil Solution for Injection 20mg/mlalpha-Tocopherol succinate
go.drugbank.com/drugs/DB14001ApprovedNutraceuticalVet approvedThis biologic action of vitamin E consequently continues to generate ongoing interest and study in whether or not its antioxidant abilities may be used to help assist in preventing or treating a number … Alpha-tocopherol is the primary form of vitamin E that is preferentially used by the human body to meet appropriate dietary requirements.
Mixtures: For Men, Ni-C-E-LE PlusCategories: Compounds used in a research, industrial, or household settingDiamorphine
go.drugbank.com/drugs/DB01452ApprovedIllicitAs heroin, it is illegal to manufacture, possess, or sell in the United States and the UK. However, under the name diamorphine, heroin is a legal prescription drug in the United Kingdom. … Sale is forbidden in the United States by Federal statute. (Merck Index, 11th ed) Internationally, diamorphine is controlled under Schedules I and IV of the Single Convention on Narcotic Drugs.
Categories: Drugs Used in Opioid Dependence, Drugs Used in Addictive DisordersSynonyms: O,O'-DiacetylmorphineRasburicase
go.drugbank.com/drugs/DB00049ApprovedInvestigationalThe cDNA coding for rasburicase was cloned from a strain of _Aspergillus flavus_. … Rasburicase is a recombinant urate-oxidase enzyme produced by a genetically modified <i>Saccharomyces cerevisiae</i> strain.
Categories: Detoxifying Agents for Antineoplastic TreatmentProducts: FASTURTEC POWDER FOR SOLUTION FOR INFUSION 1.5 mg/vialAcyclovir
go.drugbank.com/drugs/DB00787ApprovedInvestigational[L7303,L7315,L7318,L7321,L7324,L7327] Acyclovir is generally used first line in the treatment of these viruses and some products are indicated for patients as young as 6 years old. … [L7321] Acyclovir was granted FDA approval on 29 March 1982.[L7318]
Categories: Antivirals for Systemic Use, Antiinfectives for Systemic UseProducts: ZOVIRAX IV FOR INFUSION 250MG, ALVOLES POWDER FOR SOLUTION FOR INFUSION 250MG/VIAL